Advertisement

Topics

Zafgen presents Phase II data from Type 2 diabetes drug currently on FDA hold

12:05 EDT 13 Jun 2019 | MedCity News

diabetes, diabetics, blocks

An analyst called the data, on ZGN-1061, encouraging in a relatively small study but added that more preclinical data will be needed to give a clearer picture of the way forward for the drug.

Original Article: Zafgen presents Phase II data from Type 2 diabetes drug currently on FDA hold

NEXT ARTICLE

More From BioPortfolio on "Zafgen presents Phase II data from Type 2 diabetes drug currently on FDA hold"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...